- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-5076
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Antiangiogenic therapy in breast cancer ; volume:10 ; number:4 ; day:6 ; month:11 ; year:2017 ; pages:194-201 ; date:12.2017
Magazine of European Medical Oncology ; 10, Heft 4 (6.11.2017), 194-201, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Gampenrieder, Simon Peter
- Beteiligte Personen und Organisationen
-
Westphal, Theresa
Greil, Richard
SpringerLink (Online service)
- DOI
-
10.1007/s12254-017-0362-0
- URN
-
urn:nbn:de:1111-201802081840
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gampenrieder, Simon Peter
- Westphal, Theresa
- Greil, Richard
- SpringerLink (Online service)
Ähnliche Objekte (12)
Antiangiogenic therapy reverses the immunosuppressive breast cancer microenvironment
Antiangiogenic therapy
Antiangiogenic gene therapy of cancer: recent developments
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
Resistance to chemotherapy and anti-angiogenic therapy in ovarian cancer
Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy
Antiangiogenic therapies in ovarian cancer
Hypothesis: primary antiangiogenic method proposed to treat early stage breast cancer
Characterization of anti-angiogenic therapy response in glioblastoma
18F-labeled magnetic nanoparticles for monitoring anti-angiogenic therapeutic effects in breast cancer xenografts
Antiangiogenic therapy: how far is it to upgrade?
Antiangiogenic therapy reverses the immunosuppressive breast cancer microenvironment
Antiangiogenic therapy
Antiangiogenic gene therapy of cancer: recent developments
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
Resistance to chemotherapy and anti-angiogenic therapy in ovarian cancer
Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy
Antiangiogenic therapies in ovarian cancer
Hypothesis: primary antiangiogenic method proposed to treat early stage breast cancer
Characterization of anti-angiogenic therapy response in glioblastoma
18F-labeled magnetic nanoparticles for monitoring anti-angiogenic therapeutic effects in breast cancer xenografts
Antiangiogenic therapy: how far is it to upgrade?
Antiangiogenic therapy reverses the immunosuppressive breast cancer microenvironment
Antiangiogenic therapy
Antiangiogenic gene therapy of cancer: recent developments
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
Resistance to chemotherapy and anti-angiogenic therapy in ovarian cancer
Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy
Antiangiogenic therapies in ovarian cancer
Hypothesis: primary antiangiogenic method proposed to treat early stage breast cancer
Characterization of anti-angiogenic therapy response in glioblastoma
18F-labeled magnetic nanoparticles for monitoring anti-angiogenic therapeutic effects in breast cancer xenografts